Medical Cannabis

Articles

Otha Smith III shares his personal journey with medical cannabis and how it led to founding the Tetragram app.

Tetragram Provides Cannabis Users a Safe Environment to Explore the Medicinal Benefits of the Plant

In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report.

Medical Cannabis Is Here and It’s Here to Stay: How Americans for Safe Access, the Nation’s Largest Member-Based Cannabis Advocacy Organization, Protects Patient Rights

In this article, regulatory requirements are explored as they are meant to create confidence that cannabis and cannabis-infused products are safe to use.

Improving Quality in Cannabis Testing Laboratories: Making ISO/IEC 17025 Work for Your Laboratory and Customers

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


Dr. Richard van Breemen from the Department of Pharmaceutical Sciences in the Oregon State University College of Pharmacy discusses his COVID-19 and cannabis research.

Cannabinoids and COVID-19: An Interview with Professor Richard van Breemen of Oregon State University

Dr. Alison Draisin discusses her work at the forefront of cannabis assisted psychotherapy and psychedelic assisted psychotherapy.

Reaching a Higher Dimension:  Conversation with Dr. Alison Draisin, Leading Assisted Psychedelic Psychotherapist

In this piece, we touch on the benefits and challenges associated with autoflowering genetics, and provide justification for why these unique varietals may be the catalyst for making cannabis medicine more accessible and approachable for the general population. 

Autoflowering Genetics Present Unique Opportunities

 is a Princeton, New Jersey-based psychiatrist, writer, speaker, educator, and consultant. He is the founder and board president of Doctors for Cannabis Regulation. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. He serves on the editorial board of 

Working with Doctors for Cannabis Regulation and other stakeholders, David L. Nathan, MD, proposed the Universal Cannabis Product Symbol (UCPS) in 2019. After its publication in 2020, a broad discussion with various stakeholders led to a series of changes to the UCPS. Working with the standards organization ASTM, the authors of this paper co-designed a modified version of the UCPS, which was renamed the International Intoxicating Cannabis Product Symbol (IICPS). This article presents the IICPS and next steps for the industry to start implementing its use.

Why All Legalized U.S. Jurisdictions Should (and Probably Will) Adopt the International Intoxicating Cannabis Product Symbol (IICPS)


The Massachusetts Cannabis Control Commission recently announced several appointments so their Cannabis Advisory Board, the members of which will study and make recommendations to the Commission regarding the regulation and taxation of marijuana in the state.

Massachusetts Cannabis Advisory Board Appointees Announced by Treasurer Goldberg

Dr. Denise Vidot shares some of her research findings that examine the impact of phytocannabinoids on multiple diseases.

Exploring the Impact of Cannabis on the Human Brain, Heart, and Gut

Medical cannabis patients and adult-use consumers alike are faced with an overwhelming amount of options when they first enter a dispensary. Across the industry, producers are looking for ways to simplify things for consumers. One company, Volunteer Botanicals, recently partnered with an investment group to create cannabidiol (CBD)-based tablets that also combine other cannabinoids and have the potential to create a unique consumer experience. In this interview, Jason Pickle, co-founder and chief sales officer for Volunteer Botanicals, sits down to discuss this recent product, the need for standardization throughout the cannabis industry, and more.